Upadacitinib superior to placebo in moderate-to-severe Crohn disease
by Elana GotkineFor patients with moderate-to-severe Crohn disease, upadacitinib induction and maintenance treatment are superior to placebo, according to a study published in the May 25 issue of the&
Updated on: February 19,2024
18
Upadacitinib superior to placebo in moderate-to-severe Crohn disease
by Elana GotkineFor patients with moderate-to-severe Crohn disease, upadacitinib induction and maintenance treatment are superior to placebo, according to a study published in the May 25 issue of the&
Updated on:February 19,2024
18
